Amarin Corporation (AMRN)
NASDAQ: AMRN
· Real-Time Price · USD
19.64
-0.43 (-2.14%)
At close: Oct 17, 2025, 3:59 PM
20.04
2.04%
After-hours: Oct 17, 2025, 05:08 PM EDT
-2.14% (1D)
| Bid | 19.31 |
| Market Cap | 406.21M |
| Revenue (ttm) | 193.24M |
| Net Income (ttm) | -103.59M |
| EPS (ttm) | -5 |
| PE Ratio (ttm) | -3.93 |
| Forward PE | -34.43 |
| Analyst | Sell |
| Dividends | n/a |
| Ask | 20.04 |
| Volume | 60,086 |
| Avg. Volume (20D) | 75,515 |
| Open | 19.56 |
| Previous Close | 20.07 |
| Day's Range | 19.25 - 20.26 |
| 52-Week Range | 7.00 - 20.65 |
| Beta | 0.63 |
| Ex-Dividend Date | n/a |
About AMRN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AMRN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AMRN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAmarin Corporation is scheduled to release its earnings on
Oct 29, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+27.3%
Amarin shares are trading higher after the company...
Unlock content with
Pro Subscription
7 months ago
-14.98%
Amarin Corporation shares are trading lower after the company announced its intent to effect a 1-for-20 ADS ratio change. The company reported Q4 financial results.
2 weeks ago · seekingalpha.com
Amarin: Vascepa's Global Pivot From U.S. Squeeze To International BoomAmarin (AMRN) is transforming Vascepa from a declining U.S. business into a global cardiovascular growth story, driven by disciplined expense control and strategic partnerships. AMRN's European and Re...
